+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Misdistribution of iron and oxidative stress in chronic kidney disease



Misdistribution of iron and oxidative stress in chronic kidney disease



Free Radical Biology and Medicine 2018



Chronic kidney disease (CKD) patients have an extremely high risk of developing cardiovascular diseases (CVD) compared to the general population. Systemic inflammation associated with oxidative stress could be an important determinant of morbidity and mortality associated with CVD. We suspected that dysregulation of iron metabolism should be considered in these patients. Anemia is prevalent in CKD patients and is often treated with erythropoiesis-stimulating agents (ESAs) and iron. In addition, iron administration sometimes causes iron overdose. Excessive iron in the cytosol and mitochondria can accelerate the formation of a highly toxic reactive oxygen species, hydroxyl radicals, which damage lipids, proteins, and DNA. In this review, we propose the following four major reasons for oxidative stress in CKD patients: 1) iron is sequestered in cells by proinflammatory cytokines and hepcidin; 2) the reduction in frataxin increases "free" iron in mitochondria; 3) the accumulation of 5-aminolevulinic acid, a heme precursor, has toxic effects on iron and mitochondrial metabolism; and 4) the elevated levels of the metabolic hormone, leptin, promote hepatic hepcidin production. Although an efficient therapy for preventing oxidative stress in these patients has not yet been well defined, we propose that ESAs for renal anemia may ameliorate these causes of oxidative stress. Further clinical trials are necessary to clarify the effectiveness of ESAs on oxidative stress in CKD patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 065322279

Download citation: RISBibTeXText

PMID: 29958932

DOI: 10.1016/j.freeradbiomed.2018.06.025


Related references

Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney International 65(6): 2279-2289, 2004

Oxidative Stress and Inflammation in Chronic Kidney Disease: Role of Intravenous Iron and Vitamin D. Journal of Pharmacy Practice 21(3): 214-224, 2008

Urinary Iron Excretion is Associated with Urinary Full-Length Megalin and Renal Oxidative Stress in Chronic Kidney Disease. Kidney and Blood Pressure Research 43(2): 458-470, 2018

Chronic kidney disease influences multiple systems: describing the relationship between oxidative stress, inflammation, kidney damage, and concomitant disease. Oxidative Medicine and Cellular Longevity 2015: 806358, 2015

Curcumin Ameliorates Kidney Function and Oxidative Stress in Experimental Chronic Kidney Disease. Basic and Clinical Pharmacology and Toxicology 122(1): 65-73, 2017

Indoxyl sulfate-lowering capacity of oral sorbents affects the prognosis of kidney function and oxidative stress in chronic kidney disease. Journal of Renal Nutrition 17(1): 48-52, 2007

Oxidative Stress in Chronic Kidney Disease. Oxidative Medicine and Cellular Longevity 2016: 8375186, 2017

Oxidative stress in chronic kidney disease. Nephrology Nursing Journal 32(6): 683-685, 2006

Oxidative stress and chronic kidney disease. Veterinary Clinics of North America. Small Animal Practice 38(1): 157-66, Vi, 2008

Oxidative stress in chronic kidney disease. Pediatric Nephrology 2018, 2018

Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury-Mediated Chronic Kidney Disease: Role of Oxidative Stress. Hypertension 69(5): 870-878, 2017

The role of oxidative stress in chronic kidney disease. Seminars in Dialysis 22(4): 405-408, 2010

Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease. Therapeutic Apheresis and Dialysis 15(2): 125-128, 2011

Role of oxidative stress on chronic kidney disease progression. Acta Medica Indonesiana 46(3): 244-252, 2015

Oxidative stress and inflammation in stage 3-5 chronic kidney disease. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 466A, September, 2002